221 related articles for article (PubMed ID: 30190863)
1. The potential complementary role of targeted alpha therapy in the management of metastatic melanoma.
Brown MP; Bezak E; Allen BJ
Melanoma Manag; 2015 Nov; 2(4):353-366. PubMed ID: 30190863
[TBL] [Abstract][Full Text] [Related]
2. Targeted alpha therapy for cancer.
Allen BJ; Raja C; Rizvi S; Li Y; Tsui W; Zhang D; Song E; Qu CF; Kearsley J; Graham P; Thompson J
Phys Med Biol; 2004 Aug; 49(16):3703-12. PubMed ID: 15446799
[TBL] [Abstract][Full Text] [Related]
3. In vitro and preclinical targeted alpha therapy of human prostate cancer with Bi-213 labeled J591 antibody against the prostate specific membrane antigen.
Li Y; Tian Z; Rizvi SM; Bander NH; Allen BJ
Prostate Cancer Prostatic Dis; 2002; 5(1):36-46. PubMed ID: 15195129
[TBL] [Abstract][Full Text] [Related]
4. Targeted alpha anticancer therapies: update and future prospects.
Allen BJ; Huang CY; Clarke RA
Biologics; 2014; 8():255-67. PubMed ID: 25422581
[TBL] [Abstract][Full Text] [Related]
5. Preclinical targeted alpha therapy for subcutaneous melanoma.
Allen BJ; Rizvi SM; Tian Z
Melanoma Res; 2001 Apr; 11(2):175-82. PubMed ID: 11333128
[TBL] [Abstract][Full Text] [Related]
6. Tumour anti-vascular alpha therapy: a mechanism for the regression of solid tumours in metastatic cancer.
Allen BJ; Raja C; Rizvi S; Song EY; Graham P
Phys Med Biol; 2007 Jul; 52(13):L15-9. PubMed ID: 17664565
[TBL] [Abstract][Full Text] [Related]
7. Targeted alpha therapy approach to the management of pancreatic cancer.
Allen BJ; Rizvi SM; Qu CF; Smith RC
Cancers (Basel); 2011 Apr; 3(2):1821-43. PubMed ID: 24212784
[TBL] [Abstract][Full Text] [Related]
8. Targeted alpha therapy: part I.
Elgqvist J
Curr Radiopharm; 2011 Jul; 4(3):176. PubMed ID: 22201706
[TBL] [Abstract][Full Text] [Related]
9. Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.
Ascierto PA; Atkins M; Bifulco C; Botti G; Cochran A; Davies M; Demaria S; Dummer R; Ferrone S; Formenti S; Gajewski TF; Garbe C; Khleif S; Kiessling R; Lo R; Lorigan P; Arthur GM; Masucci G; Melero I; Mihm M; Palmieri G; Parmiani G; Puzanov I; Romero P; Schilling B; Seliger B; Stroncek D; Taube J; Tomei S; Zarour HM; Testori A; Wang E; Galon J; Ciliberto G; Mozzillo N; Marincola FM; Thurin M
J Transl Med; 2015 Nov; 13():374. PubMed ID: 26619946
[TBL] [Abstract][Full Text] [Related]
10. Targeted alpha therapy: evidence for potential efficacy of alpha-immunoconjugates in the management of micrometastatic cancer.
Allen BJ
Australas Radiol; 1999 Nov; 43(4):480-6. PubMed ID: 10901964
[TBL] [Abstract][Full Text] [Related]
11. In vitro and preclinical targeted alpha therapy for melanoma, breast, prostate and colorectal cancers.
Allen BJ; Rizvi S; Li Y; Tian Z; Ranson M
Crit Rev Oncol Hematol; 2001; 39(1-2):139-46. PubMed ID: 11418311
[TBL] [Abstract][Full Text] [Related]
12. Revisiting the Radiobiology of Targeted Alpha Therapy.
Pouget JP; Constanzo J
Front Med (Lausanne); 2021; 8():692436. PubMed ID: 34386508
[TBL] [Abstract][Full Text] [Related]
13. Targeted Radionuclide Therapy of Melanoma.
Norain A; Dadachova E
Semin Nucl Med; 2016 May; 46(3):250-9. PubMed ID: 27067506
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant therapy of malignant melanoma and the role of sentinel node mapping.
Eggermont AM
Recent Results Cancer Res; 2000; 157():178-89. PubMed ID: 10857171
[TBL] [Abstract][Full Text] [Related]
15. Development of Targeted Alpha Particle Therapy for Solid Tumors.
Tafreshi NK; Doligalski ML; Tichacek CJ; Pandya DN; Budzevich MM; El-Haddad G; Khushalani NI; Moros EG; McLaughlin ML; Wadas TJ; Morse DL
Molecules; 2019 Nov; 24(23):. PubMed ID: 31779154
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of (68)Ga- and (177)Lu-DOTA-PEG4-LLP2A for VLA-4-Targeted PET Imaging and Treatment of Metastatic Melanoma.
Beaino W; Nedrow JR; Anderson CJ
Mol Pharm; 2015 Jun; 12(6):1929-38. PubMed ID: 25919487
[TBL] [Abstract][Full Text] [Related]
17. Analysis of patient survival in a Phase I trial of systemic targeted α-therapy for metastatic melanoma.
Allen BJ; Singla AA; Rizvi SM; Graham P; Bruchertseifer F; Apostolidis C; Morgenstern A
Immunotherapy; 2011 Sep; 3(9):1041-50. PubMed ID: 21913827
[TBL] [Abstract][Full Text] [Related]
18. Application of
Yong K; Brechbiel M
AIMS Med Sci; 2015; 2(3):228-245. PubMed ID: 26858987
[TBL] [Abstract][Full Text] [Related]
19. Systemic targeted alpha radiotherapy for cancer.
Allen B
J Biomed Phys Eng; 2013 Sep; 3(3):67-80. PubMed ID: 25505750
[TBL] [Abstract][Full Text] [Related]
20. Intralesional and systemic immunotherapy for metastatic melanoma.
Luu C; Khushalani NI; Zager JS
Expert Opin Biol Ther; 2016 Dec; 16(12):1491-1499. PubMed ID: 27602429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
